Product Information
TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.0840 per ML under NDC 68180096256. Its NADAC has been published 225 times since Apr 13, 2022.
FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AN.
Strength
300 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180096256
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA208964FDA Approved
3/22/2017
TE Code
AN
On Market Since
6/12/2018
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 225 times since Apr 13, 2022, and over the history we have for it it has declined 71.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0840 per ML |
|---|---|
| All-time high | $3.7654 (May 11, 2022) |
| All-time low | $1.0672 (Mar 18, 2026) |
| 52-week high | $1.4721 |
| 52-week low | $1.0672 |
| Median price | $1.7103 |
| Average price | $1.8008 |
| Largest weekly change | -33.9% (Nov 20, 2024) |
| Weeks tracked | 225 |
| Tracking since | Apr 13, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tobramycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Lupin Pharmaceuticals Inc., is $1.0840 per ML (NDC 68180096256), effective Sep 30, 2026.
How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 71.2%. It has been tracked across 225 weekly CMS publications since Apr 13, 2022.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?
Since Apr 13, 2022, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0672 (Mar 18, 2026) to a high of $3.7654 (May 11, 2022), with a median of $1.7103 per ML.
Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?
TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 68180096256) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.